NATALIE WILLS: Open Payments
NPI 1245926393 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$856 in 15 payments from 8 companies in 2025. Trend: 2023 $135 · 2024 $789 · 2025 $856
Food & beverage: $856
| Company | Payments | Amount |
|---|---|---|
| Penumbra, Inc. | 3 | $213 |
| Boston Scientific Corporation | 2 | $191 |
| ABBVIE INC. | 1 | $127 |
| CashFlow Solutions, LLC | 5 | $119 |
| Novo Nordisk Inc | 1 | $108 |
| Koya Medical, Inc. | 1 | $51 |
| ABIOMED | 1 | $30 |
| Solventum Corporation | 1 | $17 |
Products named: ENROUTE Transcarotid Neuroprotection System, Indigo System, BOTOX, LYMPHA PRESS OPTIMAL PLUS(US) BT, Wegovy, Penumbra System, KOYA MEDICAL, PREVENA.
Industry payments across NJ — which companies pay providers there.
